in terms of treatment completion, 27 participants were administered a combined treatment of cagrilintide and semaglutide, 28 participants were administered semaglutide, and 30 were administered cagrilintide
[35] But, whats impressive about this peptide is that it can accelerate the healing of almost any injury internal or external
Although, much of the hype about this medication is true, it is still a pharmaceutical medication which MUST be prescribed by a physician who is familiar with the effects and side effects of this medication and furthermore has appropriate guidelines as to which individuals are appropriate candidates to use this medication
The FDA restricts GLP-1 agonists (semaglutide, tirzepatide, retatrutide) to prescription status because metabolic pathways, kidney function, thyroid history, and cardiovascular factors must be assessed before initiation
And so from that point, we can say, okay, so there are things that need to be kept with a human
Cost should be discussed before treatment begins, not after the medication starts working
